Commit To Buy Terns Pharmaceuticals At $20, Earn 36.5% Annualized Using Options

Selling an April 2026 $20 put on Terns Pharmaceuticals (TERN) would net a $3 premium—implying a $17 per‑share cost basis if assigned and a 36.5% annualized yield—with assignment occurring only if the stock falls about 24.1% from today’s $26.77. The rich premium reflects elevated risk: TERN’s trailing 12‑month volatility is 93%, so put sellers’ upside is limited to the premium while facing meaningful downside if shares plunge. Prospective sellers should weigh that risk versus their fundamental view before using this trade.

Analysis

The article describes an April 2026 $20 put sale on Terns Pharmaceuticals (TERN) that generates a $3 premium today given a $26.77 share price, which implies a $17 per‑share effective cost if assigned and a quoted 36.5% annualized return; assignment would occur only if the stock drops roughly 24.1% to the $20 strike. The analysis notes the seller’s upside is capped at the premium while downside includes ownership at $17 if exercised, so the strategy does not participate in upside like outright share ownership would.

Risk metrics are prominent: the stock’s trailing 12‑month volatility is stated at 93%, which helps explain the rich premium and signals a high probability of large price moves versus lower‑volatility names. That elevated volatility increases the chance of the option moving into the money and magnifies potential mark‑to‑market losses before expiration.

Investability hinges on fundamentals and risk tolerance: the put sale may be attractive only to investors comfortable owning TERN at a $17 basis and accepting biotech‑level volatility, whereas those seeking upside participation should prefer shares. Sellers should combine this options view with independent fundamental conviction and position sizing given the pronounced volatility and limited payoff profile of the trade.

Key Decisions for Investors

• Only consider selling the April 2026 $20 put if you are willing to own TERN at an effective $17 per share and have a positive fundamental conviction in the company
• Size the position conservatively and limit allocation given TERN's 93% trailing volatility and the non‑linear downside risk if assigned
• If downside protection is desired, convert the trade to a put spread or buy a cheap protective put to cap assignment losses, otherwise accept that upside is limited to the $3 premium
• Reassess the trade if TERN approaches the $20 strike, if realized volatility materially changes, or if company fundamentals diverge from your thesis